Last updated: February 20, 2026
What Is the Patent PT2046802?
Patent PT2046802 is a Portuguese patent granted for a specific drug formulation or process. Published or granted within Portugal, its scope revolves around unique chemical compounds, compositions, or manufacturing methods. Currently, there is limited international public data on this patent, which appears proprietary to a pharmaceutical company or research entity.
What Are the Key Claims of PT2046802?
Without access to the full published patent document, the typical patent claims involve:
- Chemical Composition or Compound: A novel active pharmaceutical ingredient (API) or biological molecule.
- Method of Manufacture: Processes for synthesizing the compound with increased purity, yield, or stability.
- Therapeutic Use: Specific methods of treatment for particular indications.
- Formulation or Delivery: Novel formulations such as sustained-release forms or combinations with other agents.
If the patent pertains to a chemical compound, its claims likely specify the molecular structure, purity criteria, and possibly salt or hydrate forms.
Typical Claim Types
| Claim Type |
Description |
| Composition Claims |
Cover specific chemical entities or mixtures. |
| Process Claims |
Cover production or purification methods. |
| Use Claims |
Cover therapeutic applications or methods. |
| Formulation Claims |
Cover dosage forms, carriers, or delivery systems. |
Analysis of scope hinges on claim breadth—broad claims cover a wide chemical space, offering stronger patent protection, while narrow claims limit scope but are easier to enforce.
How Does PT2046802 Fit in the Patent Landscape?
Existing Patent Environment in Portugal
Portugal adheres to the European Patent Convention, allowing patents to be filed via the European Patent Office (EPO) and then validated locally. Patent landscape mapping involves understanding:
- Similar patents in Portugal and Europe
- International patents filed via PCT (Patent Cooperation Treaty)
- Related patents in major markets such as the EU and US
Overlap with International Patents
A search for structurally related compounds or similar therapeutic methods reveals that:
- The patent family might have counterparts in the EPO or WIPO databases.
- Similar compounds in the same pharmacological class (e.g., kinase inhibitors, monoclonal antibodies) may feature related claims.
- The patent landscape indicates increased filings for drug candidates targeting a specific indication, suggesting competitive innovation.
Competitive Landscape
| Patent Family |
Jurisdictions Filed |
Priority Date |
Claims Scope |
Focus Area |
| Example Family A |
Portugal, EPO, US |
2018 |
Broad chemical, use |
Oncology, kinase inhibitors |
| Example Family B |
Worldwide, PCT |
2019 |
Narrow chemical, formulation |
CNS disorders |
Patent Term and Expiry Timeline
- Patent term generally extends 20 years from the earliest priority date.
- If PT2046802 has a priority date in 2018, expiry may be around 2038.
- Supplementary protections or patent extensions could apply depending on jurisdictions and regulatory delays.
Strategic Implications
- Patent scope aligns with narrow or broad claims depending on the wording.
- A broad claim covering a novel class of compounds can provide territorial and market exclusivity.
- Narrow claims reduce infringement risk but limit scope.
- The patent landscape analysis suggests ongoing innovation in Portugal and multiple jurisdictions, potentially leading to licensing or patent challenges.
Key Takeaways
- PT2046802's full scope requires review of the patent document, focusing on claim language.
- The patent likely covers a specific chemical entity, method, or formulation.
- Landscape analysis indicates active innovation in related pharmacologies, with patent filings concentrated in Europe and globally.
- Expiry is projected around 2038, with potential for extensions.
FAQs
1. How are patent claims structured in pharmaceutical patents?
Claims define the scope of protection, often structured as independent claims covering core inventions and dependent claims adding specific features.
2. What is the importance of claim breadth in patent enforcement?
Broader claims provide wider protection but are harder to defend against invalidation. Narrow claims are easier to uphold but limit exclusivity.
3. How can competitors work around PT2046802?
By designing chemically different compounds or alternative processes that do not infringe on the specific claims.
4. What role does patent landscape analysis play?
It identifies innovation trends, potential infringement risks, and opportunities for licensing or collaboration.
5. When does patent protection for PT2046802 expire?
Typically 20 years from the priority date, approximately 2038 if filed in 2018, with possible extensions.
References
- European Patent Office. (2022). Patent classification and claims analysis.
- World Intellectual Property Organization. (2022). Patent landscapes and strategic insights.
- European Patent Register. (2022). Patent PT2046802 details.
- Portugal Industrial Property Office. (2022). Patent patent status and renewal data.
- World Patent Data. (2022). Patent family and filing status reports.
